GlassScriptPhysician profile
Matt G Farzin
NPI 1386783108
$1,490.14
in general payments reported to CMS, 2019-2025
7 companies · $38.75 in 2025
The $38.75 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $283 · 2021: $173 · 2022: $242 · 2023: $273 · 2024: $108 · 2025: $38.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $152.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orapharma, A Division of Bausch Health US, LLC | $1,117.32 | 2019-2024 | Arestin |
| Straumann USA LLC | $152.76 | 2023 | |
| Align Technology, INC. | $102.86 | 2023-2025 | Itero Element 5d Plus Lite, Itero Element 5d Plus, Invisalign |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.10 | 2021-2022 | |
| Kulzer, LLC | $21.80 | 2019 | |
| Dentsply Sirona INC | $18.87 | 2025 | Tph Spectra Universal Composite Restorative Low Viscosity |
| Philips North America LLC | $16.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matt Farzin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.